Revised Banner 3

Previous Year's Programs

View speakers, slides, and presentations from previous year's symposiums.

 


*This program was developed independently by the Barbara Davis Center for Diabetes and supported in part by an educational grant from Sanofi US. 

9th Symposium on General Population Screening for T1D

November 9-10, 2026

Barbara Davis Center for Diabetes

The symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of monitoring and supporting children with early-stage T1D, as well as the combined screening for both T1D and celiac disease. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.

 


 

  • Jointly provided by Postgraduate Institute for Medicine and Barbara Davis Center for Diabetes 
  • This activity is supported by an independent educational grant from Sanofi.

 


 

Target Audience: Healthcare professionals including MD, DO, advanced practice providers, nurses, pharmacists, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies.

Learning Objectives:

1) Review the latest consensus guidelines and global evidence supporting early detection and screening for stage 1 and 2 type 1 diabetes (T1D) in the general population.

2) Explain advancements in islet autoantibody screening methods, including laboratory techniques and strategies for staging and risk stratification.

3) Explain best practices for confirming positive screening results and communicating findings to families and patients.

4) Discuss emerging interventions, clinical trials, and implementation strategies aimed at delaying or preventing progression to symptomatic T1D.

5) Collaborate with interdisciplinary teams to address challenges in screening implementation, patient monitoring, and integration into clinical workflows across healthcare systems.

*Open to all Anschutz Medical Campus faculty and staff.

Please use this link for questions

 

 

Disclosure of Financial Relationships

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The PIM planners and others have nothing to disclose. 

Financial relationships of faculty and planners are under review. Any relevant financial relationships identified will be mitigated prior to the activity and disclosed to learners.

Joint Accreditation Statement

Joint Accrediation

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Barbara Davis Center.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 14.5 contact hours.

 Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 14.5 contact hour(s) (1.45 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-26-568-L99-P ) 

Type of Activity: Knowledge

 

(**Credit hours are subject to change based on the final review and approval of course content and instructional materials. **)

 

Americans with Disabilities Act (required for live meetings only)

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Christy Vasey prior to the live event at (303) 724-9787 or email christy.vasey@cuanschutz.edu.

 Fee Information

No fee 

 

 

 

 

 


 

Barbara Davis Center

CU Anschutz

Barbara Davis Center for Diabetes

1775 North Aurora Court

Aurora, CO 80045


303-724-2323

CMS Login